Kyntra Bio KYNB
NASDAQ KYNB
$3.35 -0.14 (-4.15%)
As of: Nov 16, 2026 · 10:25 AM EST

Kyntra Bio (KYNB) Acquisitions (2020)

Updated

Kyntra Bio (KYNB) reported Acquisitions of $656,000 for FY2023.

Analysis

Kyntra Bio (KYNB) Acquisitions (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,304.33 Bn 1,277.95 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 692.09 Bn 611.95 Bn 17.30 Bn -17.15 Bn
3 AbbVie 527.57 Bn 495.58 Bn 13.12 Bn 10.59 Bn
4 Merck 366.55 Bn 329.49 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 315.36 Bn 288.60 Bn - -
6 Astrazeneca 289.39 Bn 262.91 Bn 13.26 Bn -
7 Amgen 255.08 Bn 206.73 Bn 7.58 Bn -
8 Gilead Sciences 212.20 Bn 187.31 Bn 6.73 Bn 19.00 Mn
9 Pfizer 166.64 Bn 114.00 Bn 12.56 Bn -
10 Kyntra Bio 13.08 Mn -394.87 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 726,000.00
API Access

Kyntra Bio Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=KYNB&period=max&api_key=YOUR_API_KEY